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Abstract
Purpose To assess cognitive interference processing in adults with childhood craniopharyngioma (CP), with and without
hypothalamic injury, respectively, in terms of behavioral performance and functional magnetic resonance imaging (fMRI)
activity, using the multi-source interference task (MSIT).
Methods Twenty-eight CP patients (median age 34.5 [29.0–39.5] years) were investigated at median 20.5 (16.3–28.8) years
after treatment with surgical resection and in some cases additional radiotherapy (n= 10) and compared to 29 matched
controls (median age 37.0 [32.5–42.0] years). The subjects performed the MSIT during fMRI acquisition and behavioral
performance in terms of response times (ms) and accuracy performance (%) were recorded.
Results The MSIT activated the cingulo-fronto-parietal (CFP) attention network in both CP patients and controls. No
differences were found in behavioral performance nor fMRI activity between CP patients (interference effect 333.9
[287.3–367.1] ms and 3.1 [1.6–5.6]%, respectively) and controls (309.1 [276.4–361.0] ms and 2.6 [1.6–4.9]%). No dif-
ferences were found in behavioral performance nor fMRI activity between the two subgroups with (332.0 [283.6–353.4] ms
and 4.2 [2.3–5.7]%, respectively) and without hypothalamic injury (355.7 [293.7–388.7] ms and 2.1 [1.0–5.2]%, respec-
tively), respectively, and controls.
Conclusion Adults with childhood CP performed cognitive interference processing equally well as controls and demon-
strated no compensatory fMRI activity in the CFP attention network compared to controls. This was also true for the two
subgroups with and without hypothalamic injury. The results can be useful to better characterize this condition, and to
optimize treatment and support for these individuals.
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Introduction
Craniopharyngioma (CP) is a rare, benign, embryonic
pituitary tumor with an aggressive growth pattern and high
recurrence rate, associated with increased mortality and
morbidity in cardiovascular disease [1–6]. Adults with
childhood CP, especially patients with hypothalamic
involvement, are also at risk of cognitive impairment with
deficits in memory, attention, and processing speed, even on
complete hormone replacement therapy [7]. These deficits
are thought to be due to both the tumor itself and its
treatment, including surgical removal and additional cranial
radiotherapy (CRT), leading to hypothalamic injury [8].
It has been hypothesized that the focal hypothalamic lesion
induces changes in hypothalamic networks through the
processes of diaschisis, i.e., altered function of an neuroa-
natomical structure due to damage in another remotely
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connected structure, and/or transneuronal degeneration, i.e.,
neuronal degeneration due to damage of nearby neurons,
which may also contribute to the cognitive impairment in
these individuals [9].
A previous study using magnetic resonance imaging
(MRI) voxel-based morphometry have demonstrated
reduced gray and white matter volumes in the limbic areas
connected to the hypothalamus and an association between
impaired long-term memory and reduced gray matter
volumes in the posterior cingulate cortex in adolescents
with childhood CP [10]. Another previous study using
diffusion tensor imaging (DTI), reported an association
between microstructural white matter alterations in the
dorsal cingulum and a decline in episodic visual memory,
visuospatial abilities, executive function, attention, and
processing speed in adults with childhood CP [11]. Further,
this study also reported an association between alterations in
the ventral cingulum and a decline in episodic visual
memory, and an association between alterations in the
uncinate fasciculus and a decline in semantic memory [11].
Blood-oxygen level dependent functional MRI (fMRI) is
based on the magnetic susceptibility of blood. Alterations in
the MRI signal arise due to local changes in blood oxyge-
nation, flow, and volume from the metabolism associated with
neuronal activity. Neuroimaging studies on CP patients are
scarce and, to our knowledge, only two previous studies have
used fMRI to investigate functional brain alterations in rela-
tion to cognitive function in childhood CP patients [12, 13].
However, both studies had relatively small sample sizes and
the follow-up time after treatment was relatively short.
The multi-source interference task (MSIT) can be used to
test cognitive interference processing, which is the ability to
be attentive to goal-relevant information and at the same to be
able to reject goal-irrelevant information. This has been
shown to reliably activate the cingulo-fronto-parietal (CFP)
attention network, which includes the dorsal anterior cingulate
cortex, the dorsal anterior midcingulate cortex, and the dor-
solateral prefrontal cortex that is involved in target detection,
novelty detection, error detection, decision-making, response
selection, and stimulus/response competition [14, 15]. These
regions are all partially connected through the white matter
tracts previously investigated in CP patients [11].
Our aim was to use the MSIT during fMRI to assess
cognitive interference processing in terms of behavioral
performance and fMRI activity in adults with childhood CP.
In addition, we wanted to investigate whether hypothalamic
injury had any impact on this. We hypothesized that CP
patients would exhibit longer response times, lower accu-
racy performance, and altered fMRI activity in the CFP
attention network compared to controls. Furthermore, we
suspected that these differences would be more pronounced
in patients with hypothalamic injury.
Materials and methods
Study population
Sixty-four CP patients from the Southern Region of Sweden
(population 2.5 million), who were treated at Lund Uni-
versity Hospital between 1958 and 2010, were invited to
participate in the study. Excluded subjects (n= 23) were
either assessed to be too ill (meningioma n= 1, neuromus-
cular disease n= 1, living in a home for disabled n= 2), too
busy (n= 6), investigations too stressful according to
patients (n= 2), had aneurysm clip (n= 1), did not give any
reason (n= 7), had missing medical records (n= 1) or did
not reply (n= 2). Five subjects had to withdraw from MRI
examination due to presence of either a shunt causing sig-
nificant artifacts (n= 1), pacemaker (n= 1), claustrophobia
Table 1 Characteristics of the
adults with childhood
craniopharyngioma (CP)
investigated in the present study




Males/Females (n) 11/17 5/8 5/10
Age at investigation (y) 34.5 (29.0–39.5) 33.0 (24.0–38.0) 36.0 (30.0–41.0)
Age at diagnosis (y) 12.0 (9.0–15.8) 13.0 (8.0–21.0) 12.0 (9.0–14.0)
Time from first operation (y) 20.5 (16.3–28.8) 18.0 (12.0–21.0) 23.0 (19.0–31.0)
CRT (n) 10 8 2
Target dose CRT (Gy) 50.2 (50.0–54.0) 50.0 (50.0–54.0) 52.1 (37.7–45.3)
Growth hormone (n) 21 10 11
Gonadal steroids (n) 19 10 9
Levothyroxine (n) 23 11 12
Cortisone (n) 19 10 9
Antidiuretic hormone (n) 23 9 14
Data are presented as median and quartile (first–third)
CRT cranial radiotherapy
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(n= 2), or weight restrictions (n= 1). A total of 36 subjects
completed MRI examination. One subject was excluded due
to difficulties in understanding how to perform the MSIT.
One subject was excluded due to excessive motion during
fMRI acquisition. Six subjects were excluded due to par-
tially missing fMRI data. Thus, 28 CP patients (median age
34.5 [29.0–39.5] years; 17 females) were included in the
study (Table 1). All subjects had undergone surgery and ten
subjects had also received additional CRT (median dose
50.2 [50.0–54.0] Gy) to the area of tumor growth. At the
time of investigation, the tumor location was graded retro-
spectively, based on each subjects’ medical records: intra-
sellar growth, supra-sellar growth, supra-sellar growth
toward or into the third ventricle. The latter was the criterion
for hypothalamic injury [16]. Thirteen subjects were classi-
fied as having hypothalamic injury. Subjects were investi-
gated at median 20.5 (16.3–28.8) years since first operation.
At the time of investigation, 75% of the subjects received
growth hormone therapy and were supplemented with
growth hormone median 0.6 (0.4–0.8) mg/day. Ten females
were on oral sex steroid treatment. The remaining females
had normal gonadal function according to blood tests. Seven
males needed testosterone replacement. Twenty-three sub-
jects received levothyroxine. Nine subjects had normal
adrenocorticotropic-cortisol axes and the reminder needed
hydrocortisone. None were smokers. Comparisons were
made with 29 control subjects (median age 37.0 [32.5–42.0]
years; 17 females) that were matched in regard to age,
gender, and smoking habits. The controls were recruited
from a pool of ten potential control subjects per patient,
matched for age, gender, and smoking habits, that were
selected randomly from a computerized register of the
population in the catchment area of the patients as pre-
viously described [17]. All subjects gave written informed
consent. The study was approved by the local ethics com-
mittee (DNR 2011/769).
fMRI acquisition
MRI data were acquired on a 3T MRI scanner (MAGNETOM
Skyra, Siemens Healthcare, Erlangen, Germany) equipped with
a 20-channel head/neck receiver coil. A gradient-echo EPI
sequence (TR/TE 1500/30ms/ms, 25 slices, 64 dynamic scans,
voxel size= 3 × 3 × 4mm3) was used to acquire data during
the MSIT. To perform the fMRI analyses described below, an
additional T1-weighted 3D magnetization prepared gradient-
echo (MP-RAGE) sequence (TR/TE 1900/2.54ms), with
1mm3 isotropic resolution, was also acquired.
fMRI task
The MSIT was executed in concordance with the instruc-
tions of Bush et al. [15]. In short, the subjects were given an
MRI-compatible three-button keypad and instructed that the
keypad buttons represented the numbers 1, 2, and 3 from,
left to right. The subjects were told to use the right index,
middle, and ring finger to respond. They were also
instructed that three numbers would appear in the center of
the screen every few seconds. The objective was to report,
via button-press, the identity of the displayed number that
differed from the other two distractor numbers (Fig. 1).
During the control tasks, the distractors were zeros, and the
target numbers (either 1, 2, or 3) were always placed con-
gruently with their position. During the interference tasks,
the distractors were either 1, 2, or 3, and the target numbers
(either 1, 2, or 3) were never placed congruently with their
position. After reviewing instructions, each subject per-
formed the MSIT once to make sure that they could perform
the task correctly. Next, each subject performed the MSIT
during fMRI acquisition. The subjects completed two scans
each. During each scan, four 42 s blocks of the control tasks
alternated with four 42 s of the interference tasks. Each
block consisted of 24 three digit-number combinations.
Response times (ms) and accuracy performance (%) were
recorded using E-prime 2.0 (Psychology Software Tools,
Pittsburgh, PA).
Statistical analysis of behavioral performance
Data are presented as median and quartile (first–third). The
interference effect is defined as the difference in response
time and accuracy performance between the interference
and control tasks. Comparisons were made between CP
patients and controls, and the two subgroups of CP patients
and controls, respectively, using the Mann–Whitney U test.
The Wilcoxon signed-rank test was used to compare dif-
ferences in response time and accuracy performance
Fig. 1 The objective during the multi-source interference task was to
report, via button-press, the identity of the displayed number that dif-
fered from the other two numbers. During the control tasks (upper row),
the distractors were zeros, and the target numbers (either 1, 2, or 3)
were always placed congruently with their position. During the inter-
ference tasks (lower row), the distractors were either 1, 2, or 3, and the
target numbers were never placed congruently with their position. The
correct answer for the first column is hence ‘1’, for the second ‘2’, and
for the third ‘3’
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between interference and control tasks within the groups.
Due to relatively small test samples, parameters could not
be assumed to be normally distributed and therefore non-
parametric tests were used. Calculations were made using
SPSS version 26 and results were regarded as statistically
significant if p < 0.05.
fMRI activity analysis
Lower-level analyses generated fMRI contrasts through the
subtraction of fMRI signal during the control tasks from the
interference tasks for each subject, i.e., the interference
effect. These contrasts were used in an additional higher-
level analysis to compare group means. The CP patients
were compared to controls. In addition, CP patients with
and without hypothalamic injury, respectively, were com-
pared separately to the control group. fMRI data processing
was carried out using FEAT (FMRI Expert Analysis Tool)
Version 6.00, part of FSL (FMRIB’s Software Library,
www.fmrib.ox.ac.uk/fsl. Registration to standard space
images was carried out using FLIRT and FNIRT [18–21].
The following pre-statistics processing was applied: motion
correction using MCFLIRT [19]; slice-timing correction
using Fourier-space time-series phase-shifting; non-brain
removal using BET [22]; spatial smoothing using a Gaus-
sian kernel of FWHM 5mm; grand-mean intensity nor-
malization of the entire 4D dataset by a single multiplicative
factor; high-pass temporal filtering (Gaussian-weighted
least-squares straight line fitting, with sigma= 45.0 s).
Time-series statistical analysis was carried out using FILM
with local autocorrelation correction [23]. Z (Gaussianised
T/F) statistic images were thresholded non-parametrically
using clusters determined by Z > 3.1 and a (corrected)
cluster significance threshold of p= 0.05 [24]. Higher-level
analysis was carried out using FLAME (FMRIB’s Local
Analysis of Mixed Effects) stage 1 [25–27].
Results
Behavioral performance
Results of the analyses in terms of response time (ms) and
accuracy performance (%) during the MSIT are presented in
Table 2. The reaction time was significantly increased in the
interference tasks as compared to the control tasks for both
CP patients (861.5 [786.3–926.1] ms vs. 523.2 [485.8–
576.6] ms) and controls (821.1 [770.4–891.5] ms vs. 505.9
[453.3–541.9 ms). The same was seen in the subgroup with
hypothalamic injury (858.8 [789.5–919.0] ms vs. 510.6
[490.3–582.1] ms) and in those without hypothalamic injury
(864.2 [780.0–948.6] ms vs. 527.8 [475.4–575.5] ms). The
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interference tasks as compared to the control tasks for both
CP patients (96.6 [93.8–98.4] vs. 100.0 [99.5–100.0]%) and
controls (96.9 [94.8–97.9] vs. 100.0 [99.5–100.0]%). The
same was seen in the subgroups of CP patients i.e., those
with hypothalamic injury (95.3 [93.5–97.7] vs. 99.5
[99.0–100.0]%) and those without hypothalamic injury
(97.9 [94.8–99.0] vs. 100.0 [100.0–100.0]%). There were
no significant differences in reaction time or accuracy per-
formance in neither the interference nor the control tasks
between the CP patients, or the two subgroups, with and
without hypothalamic damage, respectively, as compared to
the control group. The interference effect, regarded as the
difference in reaction time and accuracy performance
between the control and interference tasks was not sig-
nificantly different between CP patients (333.9
[287.3–367.1] ms and 3.1 [1.6–5.6]%, respectively) and
controls (309.1 [276.4–361.0] ms and 2.6 [1.6–4.9]%).
Similar, no significantly difference in the interference effect
was seen between the subgroups; i.e., those with hypotha-
lamic injury (332.0 [283.6–353.4] ms and 4.2 [2.3–5.7]%,
respectively) and those without hypothalamic injury (355.7
[293.7–388.7] ms and 2.1 [1.0–5.2]%, respectively) com-
pared to controls.
fMRI activity
Results of the analyses of fMRI activity during the MSIT
are shown in Fig. 2. The difference in fMRI activity
required to perform the more cognitively demanding inter-
ference tasks compared to the control tasks, demonstrated
fMRI activity in the CFP attention network, in both the CP
patients, the two subgroups of CP patients with and without
hypothalamic injury, respectively, and in the control group.
Comparisons between CP patients and controls, CP patients
with hypothalamic injury and controls, and CP patients
without hypothalamic injury and controls showed no sig-
nificant differences in fMRI activity between any of the
groups.
Discussion
The aim of this study was to assess cognitive interference
processing in adults with childhood CP with the MSIT
during fMRI acquisition in terms of behavioral perfor-
mance and fMRI activity. Our results show that there was
a difference in both reaction time and accuracy perfor-
mance between the interference and control tasks for
both the CP patients and controls, which confirms the
validity of the method. However, there were no differ-
ences in reaction time, accuracy performance, or fMRI
activity between any of the groups in performing the
interference tasks.
A significant difference in reaction time as well as in
accuracy performance was recorded between the more
cognitively demanding interference tasks and the control
tasks, for both the CP patients, the subgroups of CP patients
with and without hypothalamic injury, respectively, and the
controls. This indicate that the MSIT was performed
according to instructions described in the literature [14, 15].
Nevertheless, there were no differences in neither reaction
time nor accuracy performance between any of the inves-
tigated groups. The interference effect, i.e., the difference in
reaction time and accuracy performance between the inter-
ference and control tasks, also did not differ between any of
the investigated groups.
The interference effect was additionally studied regard-
ing fMRI activity and revealed activation in the CFP
attention network as expected in both groups, suggesting
that the results are reliable. Notably, the difference in fMRI
activity that was needed to solve more cognitively
demanding interference tasks compared to the control tasks
did not differ between any of the investigated groups. This
suggests that the CP patients performed cognitive inter-
ference processing on a comparable level to controls,
without any compensatory activation in the CFP attention
network.
The MSIT has previously been used to study alterations in
behavioral performance and fMRI activation in different
conditions, commonly within the field of psychiatry [28–32],
but also in patients with heart disease [33]. The results are
highly varying and only some studies acquired fMRI data
during the MSIT whereas most studies have only presented
results on behavioral performance. In previous studies using
fMRI, decreased fMRI activity in the rostral anterior cingu-
late/medial prefrontal cortex and the precuneus/posterior
cingulate cortex have been seen in patients with schizophrenia
and increased fMRI activity in the medial frontal cortex in
patients with obsessive-compulsive disorder but no differ-
ences in behavioral performance compared to controls
[28, 29]. These somewhat ambiguous results could be due to
different conditions affecting different parts of the brain and
that structures within the investigated area are responsible for
different functions. In other words, increased activity in one
area could result in the same altered behavioral performance
as decreased activity in another area.
Neuroimaging studies on childhood CP are scarce and
comparisons of the results are difficult to interpret, largely
due to methodological variations and limitations such as
small samples, different treatment protocols, and different
follow-up times (Table 3). A few previous studies have
demonstrated that white matter integrity in the investi-
gated areas correlated negatively to given radiation dose,
reduced gray and white matter volumes in the limbic
areas, and have shown a negative correlation between
long-term memory and gray matter in the posterior
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cingulate cortex [10, 34]. In another previous study, using
a subset of patients included in the present study, micro-
structural white matter integrity was assessed using DTI
and tractography and an association between decreased
integrity in the dorsal cingulum and a decline in episodic
visual memory, visuospatial abilities, executive function,
attention, and processing speed was found [11]. Further-
more, the same study found an association between
decreased integrity in the ventral cingulum and a decline
in episodic visual memory, and an association between
decreased integrity in the uncinate fasciculus and a
decline in semantic memory in adult childhood CP
patients [11].
Only two previous studies have used fMRI to study
cognitive impairment in childhood CP patients. These stu-
dies demonstrated lower fMRI activity during the premeal
test and higher fMRI activity during the post-meal test as
compared to controls [12], and differential recruitment of
fronto-limbic brain regions during emotional face recogni-
tion [13]. Even though the hypothalamus is partially con-
nected to the limbic system as well as partially to the CFP
attention network, investigated in the present study, the
investigated cognitive domains, chosen for evaluation, dif-
fers between the studies and hence comparisons of the
results to the present study are not easily interpreted
[35, 36].
Fig. 2 Mean difference in fMRI activity between the interference and
control tasks in the multi-source interference task, i.e., the difference in
neuronal activity required to perform the additionally more cognitively
demanding interference tasks compared to the control tasks, revealed
fMRI activity pattern in the cingulo-fronto-parietal attention network
as excepted but showed no significant differences between the adult
childhood craniopharyngioma (CP) patients (A) and controls (B), the
CP patients with and without hypothalamic injury (not shown here),
respectively, and controls
Endocrine (2021) 74:714–722 719
In comparison to previous studies on CP survivors that
have demonstrated cognitive deficits, and functional and
structural brain alterations, albeit using slightly different
techniques and testing slightly different cognitive domains and
neuroanatomical structures [7–13], the results of the present
study may appear somewhat contradictory. However, not all
previously investigated cognitive domains and/or neuroanato-
mical structures were affected. For example, one study using a
sub-sample of the same CP patient group as in the present
study found cognitive deficits in semantic, episodic, and visual
memory, but no deficits in working memory, executive
function, attention or processing speed [11]. In this context, the
results of the present study may not be that surprising since
cognitive interference processing is more related to executive
function and attention than to semantic, episodic, and visual
memory because it tests the ability to select and organize
relevant information and to suppress irrelevant information.
The present results are also interesting because the CFP
attention network, situated in an area where microstructural
alterations in major white matter tracts have previously been
reported [11], have never been investigated in CP survivors
before. Thus, the results of the present study should therefore
rather be considered as another piece of information required
to better characterize this condition.
To our knowledge, this is the first study that has used the
MSIT in combination with fMRI to study cognitive inter-
ference processing in adults with childhood CP. Reaction
times, accuracy performance, and fMRI activity indicate
that the MSIT was performed correctly and that the results
are reliable. Still, there are some limitations to this study.
Firstly, the study groups were, due to the rareness of the
disease and the long follow-up time, relatively small and
may have underpowered the study, leading to discarded true
differences between the investigated groups. Secondly, a
possible selection bias might have occurred when subjects
that were unable to perform the task were excluded.
In conclusion, adults with childhood CP performed
cognitive interference processing equally well as controls in
terms of response times and accuracy performance and did
not exhibit altered fMRI activity in the CFP attention net-
work during the process. This was also true for the two
subgroups with and without hypothalamic injury. However,
this does not exclude deficits in other cognitive domains or
alterations in other functional networks. Further studies are
needed to map what cognitive domains and functional
networks are affected/unaffected in CP survivors in order to
better characterize the condition and to optimize treatment
and support for these individuals.
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Code availability
Scripts containing information of settings used for data
analysis is available upon request from the corresponding
author.
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1. B. Bülow, R. Attewell, L. Hagmar, P. Malmström, C.H. Nordström,
E.M: Erfurth, Postoperative prognosis in craniopharyngioma with
respect to cardiovascular mortality, survival, and tumor recurrence. J.
Clin. Endocrinol. Metab. 83(11), 3897–3904 (1998)
2. J.W. Tomlinson, N. Holden, R.K. Hills, K. Wheatley, R.N.
Clayton, A.S. Bates, M.C. Sheppard, P.M. Stewart, Association
between premature mortality and hypopituitarism. Lancet 357
(9254), 425–431 (2001)
3. A.M. Pereira, E.M. Schmid, P.J. Schutte, J.H. Voormolen, N.R.
Biermasz, S.W. Van Thiel, E.P.M. Corssmit, J.W.A. Smit, F.
Roelfsema, J.A. Romijn, High prevalence of long‐term cardi-
ovascular, neurological and psychosocial morbidity after
treatment for craniopharyngioma. Clin. Endocrinol. 62(2),
197–204 (2005)
4. H. Holmer, B. Ekman, J. Björk, C.H. Nordstöm, V. Popovic, A.
Siversson, E.M. Erfurth, Hypothalamic involvement predicts
cardiovascular risk in adults with childhood onset craniophar-
yngioma on long-term GH therapy. Eur. J. Endocrinol. 161(5),
671–679 (2009)
5. H.L. Müller, U. Gebhardt, C. Teske, A. Faldum, I. Zwiener, M.
Warmuth-Metz, T. Pietsch, F. Pohl, N. Sörensen, G. Calaminus,
Post-operative hypothalamic lesions and obesity in childhood
craniopharyngioma: results of the multinational prospective trial
KRANIOPHARYNGEOM 2000 after 3-year follow-up. Eur. J.
Endocrinol. 165(1), 17–24 (2011)
6. D.S. Olsson, E. Andersson, I.L. Bryngelsson, A.G. Nilsson, G.
Johannsson, Excess mortality and morbidity in patients with cra-
niopharyngioma, especially in patients with childhood onset: a
population-based study in Sweden. J. Clin. Endocrinol. Metab.
100(2), 467–474 (2015)
7. S. Fjalldal, H. Holmer, L. Rylander, M. Elfving, B. Ekman, K.
Österberg, E.M. Erfurth, Hypothalamic involvement predicts
cognitive performance and psychosocial health in long-term sur-
vivors of childhood craniopharyngioma. J. Clin. Endocrinol.
Metab. 98(8), 3253–3262 (2013)
8. J. Özyurt, H.L. Müller, C.M. Thiel, A systematic review of cog-
nitive performance in patients with childhood craniopharyngioma.
J. neuro-Oncol. 125(1), 9–21 (2015)
9. H.L. Müller, Management of endocrine disease: childhood-onset
craniopharyngioma: state of the art of care in 2018. Eur. J.
Endocrinol. 180(4), R159–R174 (2019)
10. J. Özyurt, H.L. Müller, M. Warmuth-Metz, C.M. Thiel, Hypo-
thalamic tumors impact gray and white matter volumes in fronto-
limbic brain areas. Cortex 89, 98–110 (2017)
11. S. Fjalldal, C. Follin, D. Svärd, L. Rylander, S. Gabery, Å.
Petersén, D. van Westen, P.C. Sundgren, I.M. Björkman-Burt-
scher, J. Lätt, B. Ekman, A. Johanson, E.M. Erfurth, Micro-
structural white matter alterations and hippocampal volumes are
associated with cognitive deficits in craniopharyngioma. Eur. J.
Endocrinol. 178(6), 577–587 (2018)
12. C.L. Roth, E. Aylward, O. Liang, N.M. Kleinhans, G. Pauley, E.
A. Schur, Functional neuroimaging in craniopharyngioma: a
useful tool to better understand hypothalamic obesity? Obes. Facts
5(2), 243–253 (2012)
13. J. Özyurt, A. Lorenzen, U. Gebhardt, M. Warmuth-Metz, H.L.
Müller, C.M. Thiel, Remote effects of hypothalamic lesions in the
prefrontal cortex of craniopharygioma patients. Neurobiol. Learn.
Mem. 111, 71–80 (2014)
14. G. Bush, L.M. Shin, J. Holmes, B.R. Rosen, B.A. Vogt, The
Multi-Source Interference Task: validation study with fMRI in
individual subjects. Mol. Psychiatry 8(1), 60–70 (2003)
15. G. Bush, L.M. Shin, The Multi-Source Interference Task: an fMRI
task that reliably activates the cingulo-frontal-parietal cognitive/
attention network. Nat. Protoc. 1(1), 308–313 (2006)
16. S. Fjalldal, C. Follin, S. Gabery, P.C. Sundgren, I.M. Björkman-
Burtscher, J. Lätt, P. Mannfolk, C.H. Nordström, L. Rylander, B.
Ekman, R. Cheong, A. Pålsson, Å. Petersén, E.M. Erfurth,
Detailed assessment of hypothalamic damage in craniophar-
yngioma patients with obesity. Int. J. Obes. 43(3), 533–544 (2019)
17. K. Link, C. Moëll, K. Österberg, R. Persson, P. Ørbaek, S. Gar-
wicz, E. Cavallin-Ståhl, E.M. Erfurth, Adult survivors of child-
hood acute lymphoblastic leukaemia with GH deficiency have
normal self‐rated quality of life but impaired neuropsychological
performance 20 years after cranial irradiation. Clin. Endocrinol.
65(5), 617–625 (2006)
18. M. Jenkinson, S. Smith, A global optimisation method for robust
affine registration of brain images. Med. Image Anal. 5(2),
143–156 (2001)
Endocrine (2021) 74:714–722 721
19. M. Jenkinson, P. Bannister, M. Brady, S. Smith, Improved opti-
mization for the robust and accurate linear registration and motion
correction of brain images. Neuroimage 17(2), 825–841 (2002)
20. J. L. Andersson, M. Jenkinson, S. Smith, Non-linear optimisation.
FMRIB technical report TR07JA1. Practice. (2007)
21. J.L. Andersson, M. Jenkinson, S. Smith, Non-linear registration,
aka Spatial normalisation FMRIB technical report TR07JA2.
FMRIB Anal. Group Univ. Oxf. 2(1), e21 (2007)
22. S.M. Smith, Fast robust automated brain extraction. Hum. Brain
Mapp. 17(3), 143–155 (2002)
23. M.W. Woolrich, B.D. Ripley, M. Brady, S.M. Smith, Temporal
autocorrelation in univariate linear modeling of FMRI data.
Neuroimage 14(6), 1370–1386 (2001)
24. K.J. Worsley, Statistical analysis of activation images. Funct.
MRI: Introduct Methods 14(1), 251–70 (2001)
25. C.F. Beckmann, M. Jenkinson, S.M. Smith, General multilevel
linear modeling for group analysis in FMRI. Neuroimage 20(2),
1052–1063 (2003)
26. M.W. Woolrich, T.E. Behrens, C.F. Beckmann, M. Jenkinson, S.
M. Smith, Multilevel linear modelling for FMRI group analysis
using Bayesian inference. Neuroimage 21(4), 1732–1747 (2004)
27. M. Woolrich, Robust group analysis using outlier inference.
Neuroimage 41(2), 286–301 (2008)
28. B.J. Harrison, M. Yücel, J. Pujol, C. Pantelis, Task-induced
deactivation of midline cortical regions in schizophrenia assessed
with fMRI. Schizophrenia Res. 91(1–3), 82–86 (2007)
29. M. Yücel, B.J. Harrison, S.J. Wood, A. Fornito, R.M. Wellard, J.
Pujol, K. Clarke, M.L. Phillips, M. Kyrios, D. Velakoulis, C.
Pantelis, Functional and biochemical alterations of the medial
frontal cortex in obsessive-compulsive disorder. Arch. Gen. Psy-
chiatry 64(8), 946–955 (2007)
30. K.J. Allen, J.M. Hooley, Negative mood and interference
control in nonsuicidal self-injury. Compr. Psychiatry 73, 35–42
(2017)
31. T. Capri, E. Santoddi, R.A. Fabio, Multi-Source Interference Task
paradigm to enhance automatic and controlled processes in
ADHD. Res. Dev. Disabil. 97, 103542 (2020)
32. B.C. Darnell, D.P. Valentiner, Performance on the Multisource
Interference Task Moderates the Relationship Between Trauma
Exposure and Posttraumatic Stress Symptoms. Clinical. Psychol.
Sci. 8(2), 351–358 (2020)
33. M. Jung, J. Jonides, M.G. Berman, L. Northouse, T.M. Koelling,
S.J. Pressler, Construct validity of the Multi-Source Interference
Task to examine attention in heart failure. Nurs. Res. 67(6),
465–472 (2018)
34. J. Uh, T.E. Merchant, Y. Li, X. Li, N.D. Sabin, D.J. Indelicato, R.
J. Ogg, F.A. Boop, J.A. Jane Jr., C. Hua, Effects of surgery and
proton therapy on cerebral white matter of craniopharyngioma
patients. Int. J. Radiat. Oncol.* Biol.* Phys. 93(1), 64–71 (2015)
35. J.P. Aggleton, J.R. Dumont, E.C. Warburton, Unraveling the
contributions of the diencephalon to recognition memory: a
review. Learn. Mem. 18(6), 384–400 (2011)
36. J.J. Lemaire, A.J. Frew, D. McArthur, A.A. Gorgulho, J.R. Alger,
N. Salomon, C. Chen, E.J. Behnke, A.A. De Salles, White matter
connectivity of human hypothalamus. Brain Res. 1371, 43–64
(2011)
722 Endocrine (2021) 74:714–722
